CMBA
BEAT

C.M. Bidwell & Associates’s BioTelemetry, Inc. BEAT Stock Holding History

C.M. Bidwell & Associates’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,105
Closed -$69K – 478
2019
Q1 		$69K Sell
1,105
-70
-6% -$4.81K 0.07% 225
2018
Q4 		$70K Buy
1,175
+430
+58% +$25.8K 0.08% 221
2018
Q3 		$48K Buy
+745
New +$41.6K 0.05% 237

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

C.M. Bidwell & Associates's BEAT Position: Q2 2019 in Review

C.M. Bidwell & Associates sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 1,105 shares — an estimated $69K sold.

C.M. Bidwell & Associates first reported a position in BEAT in Q3 2018 and held it in 3 quarters. The position peaked at $70K in Q4 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • C.M. Bidwell & Associates reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,105 BioTelemetry, Inc. shares in Q2 2019, an estimated $69K.
  • C.M. Bidwell & Associates first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 3 quarters.
  • C.M. Bidwell & Associates's BioTelemetry, Inc. position peaked at $70K in Q4 2018.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2019, filed 7 Aug 2019.